Applied Therapeutics, Inc.
APLT
$0.3987
$0.00040.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -100.00% | -15.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -100.00% | -15.28% | |||
| Cost of Revenue | -21.13% | 48.22% | |||
| Gross Profit | 20.47% | -49.15% | |||
| SG&A Expenses | 41.83% | 42.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.57% | 45.09% | |||
| Operating Income | -11.02% | -45.51% | |||
| Income Before Tax | 164.16% | -2,466.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 164.16% | -2,466.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 164.16% | -2,466.84% | |||
| EBIT | -11.02% | -45.51% | |||
| EBITDA | -11.02% | -45.51% | |||
| EPS Basic | 164.10% | -2,464.18% | |||
| Normalized Basic EPS | 164.13% | -2,437.80% | |||
| EPS Diluted | 163.49% | -264.98% | |||
| Normalized Diluted EPS | 164.13% | -2,574.17% | |||
| Average Basic Shares Outstanding | 0.08% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.08% | -5.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||